German medtech industry "booming" in difficult climate
This article was originally published in Clinica
Executive Summary
It is becoming increasingly difficult for companies in Germany to gain reimbursement from the statutory health insurance funds for new medical technologies for the provision of care in the outpatient sector, claims a recently published economic research report.